Login

President Satoshi Ogiso: Leading the Way Forward | Satoshi Ogiso - President & CEO of Hino Motors 00:10:00

Share On Facebook Share On Twitter

Satoshi Ogiso is President/CEO/Chro at Hino Motors Ltd.

Recent Videos

00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper
00:10:00
A $10M Company with a $147M NPV:Akora Resources’ High-Grade Iron Ore Opportunity in Madagascar|Peter Bird,Managing Director,Akora Resources Limited
00:10:00
Lomiko Metals: Building North America’s Largest Undeveloped Graphite Asset with Non-Dilutive Government Backing|Gordana Slepcev,CEO,Lomiko Metals Inc
00:10:00
Apollo Silver: Building a Next-Generation Silver Champion with Flagship U.S. Assets and World-Class Growth Potential in Mexico|ROSS McELROY,CEO,Apollo Silver Crop
00:10:00
Contango Ore and Dolly Varden Silver Announce Merger to Create North American Precious Metals Powerhouse|Rick Van Nieuwenhuyse,CEO,Contango Ore
00:10:00
Turning Energy Infrastructure Into a Critical Mineral Engine|Bill McClain,Head of Investor Relations,LibertyStream Infrastucture Partners Inc
00:10:00
Cerrado Gold Eyes Massive Growth: Projecting $488 Million in Free Cash Flow by 2030|Mark Brennan,CEO,Cerrado Gold
00:10:00
Dryden Gold Accelerates Growth with $7.8M Financing and Major 2026 Drill Program in Ontario’s Prolific Gold Belt|Trey Wasser,CEO,Dryden Gold Corp
00:10:00
Sparton Resources CEO Lee Barker Targets 2025–26 Drilling at Oaks Gold Project Near Alamos Mine|Lee Barker,CEO,Sparton Resources
00:10:00
Talisker Resources Delivers First Gold Sales and Outlines 5-Year Path to 200,000+ Ounces Annual Production|Terry Harbort,CEO,Talisker Resources Ltd
00:10:00
Nuvos Therapeutics: Advancing Oxygen Nanobubble Therapy with Breakthrough Phase 2B Programs in Oncology, Stroke, and Respiratory Distress|Evan Unger,MD,NuvOx Therapeutics
00:10:00
Phenom Resources Advances Nevada Gold Portfolio with Active Drilling, Strategic Financing, and Multiple Upcoming Catalysts|Paul Cowley,CEO,Phenom Resources
00:10:00
Benton Resources Unlocks World-Class Copper-Gold Potential in Newfoundland with District-Scale Exploration Success|STEPHEN STARES,CEO,Benton Resources
00:10:00
Positioned at the Heart of Global Supply Chain Shift with UK, US, Uganda, and Brazil Projects Driving Ex-China Growth|Tim Harrison,Managing Director, Ionic Rare Earths Limited
00:10:00
Dakota Gold Unveils $2.1B Gold Project with Robust Economics, Long Mine Life, and Strategic U.S. Advantage|Robert Quartermain,CEO,Dakota Gold Corp

Suggestions

00:10:00
Therese Tucker of BlackLine: CEOs You Should Know | Therese Tucker, CEO, BlackLine Inc.
00:10:00
Developing new treatment options for cancer patients in indications with the greatest medical need|Bill Welch, CEO, Trovagene Inc
00:10:00
Launching Beyond Borders: Canada's Future in Space Exploration Inspired by Apollo 11 | MARTIN BRASSARD - PRESIDENT AND CHIEF EXECUTIVE OFFICER of Héroux-Devtek
00:10:00
Addressing Geopolitical and Economic Influences on Wealth Management Strategies | Andrew Schlossberg , CEO , Invesco.
00:10:00
ABN AMRO CEO Robert Swaak's Economic Forecast for 2023 | Robert Swaak, CEO , ABN AMRO.
00:10:00
Maximizing Savings on Medicare Part D Drug Plans: Expert Tips and Strategies from Danyel Dicicco of RBF Capital Management & Retirement Solutions
00:10:00
Exploring Asia's Investment Opportunities with Legg Mason Asset Management | Lennie Lim and Freeman Tsang
00:10:00
QC Copper and Gold: Advancing the Open Misca Project in Quebec
00:10:00
Beginner's Guide to Investing: Simple Steps to Start
00:10:00
Tarek Müller on ABOUT YOU’s Rapid Rise to the Top 3 in Fashion Retail | Tarek Müller, CEO , ABOUT YOU Holding SE.
00:10:00
Accelerating Drug Discovery Through AI and Machine Learning|Martin Brenner,CEO,Ibio Inc
00:10:00
The goal of drug developer Atossa Therapeutics is to "transform the breast cancer paradigm." | Steven C. Quay, CEO, ATOSSA THERAPEUTICS INC

© 2017 - Neuhu+